New York, USA, May 26, 2022 (GLOBE NEWSWIRE) — Drug Device Combination Market Overview
According to a Comprehensive Research Report by Market Research Future (MRFR), “Drug Device Combination Market Information by Product, Application, End User and Region – Forecast till 2030“, the market is expected to reach USD 251.90 Billion by 2030 at 7.2% CAGR.
Market Synopsis
Drug device combination devices are widely used to treat disorders such as cardiovascular diseases. The global burden of cardiovascular disease, urological disease, and others has increased in recent years. Medical devices that comprise a device and active pharmaceutical components that are chemically or physically combined as a “single-entity” are known as drug-device combination products. Due to precise medication delivery, local administration, and personalized treatment, these solutions result in safer, more effective management and treatment of various illnesses. The most common are drug-eluting stents, transdermal delivery systems, infusion pumps, inhalers, prefilled syringes, and other drug-device combo items. These cutting-edge products are being used to control and treat many chronic illnesses, including cancer, respiratory problems, cardiovascular problems, wound repair, and diabetes.
Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/6946
Report Scope:
Report Attribute | Details |
Market Size | USD 251.90 Billion |
CAGR | 7.2% |
Base Year | 2021 |
Forecast Period |